Abstract
Understanding the complex relationship between obesity and breast cancer is fundamental to our knowledge of the etiology of this malignancy; changes in the composition of the hormonal milieu are implicit in this process. Estrogens are synthesized from androgens by aromatase in the gonads and in peripheral tissues, principally, adipose tissue. Obesity in women, regardless of their age, leads to more aromatase and more extra-glandular estrogen production. In postmenopausal women, in whom ovarian estrogen production is absent, the increased incidence of breast cancer in women with high body mass index has been attributed to the relatively high plasma levels of estradiol from subcutaneous fat. In contrast, obesity in premenopausal women is associated with a previously unexplained reduced incidence of breast cancer. In obese premenopausal women, the cumulative effect of higher levels of estrogens synthesized in the peripheral tissues, together with ovarian estrogen production, results in a negative feedback on the hypothalamic pituitary controlled release of gonadotrophins and a resultant diminution in ovarian steroid production. As a consequence, the normal balance of estrogen and progesterone levels is disrupted: while estrogen levels are normalized, progesterone production is markedly decreased. Progesterone is a promoter of proliferation in the breast. The low levels of progesterone in obese premenopausal women are consistent with, and we propose, are responsible for, the reduction in breast cancer incidence in these women.
Similar content being viewed by others
References
Bhaskaran K, Douglas I, Forbes H et al (2014) Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 384:755–765
Schmitz KH, Neuhouser ML, Agurs-Collins T et al (2013) Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst 105:1344–1354
Key TJ, Appleby PN, Reeves GK et al (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95:1218–1226
Polotsky AJ, Hailpern SM, Skurnick JH et al (2010) Association of adolescent obesity and lifetime nulliparity-the study of women’s health across the nation (SWAN). Fertil Steril 93:2004–2011
Gaudet MM, Gapstur SM, Sun J et al (2014) Oophorectomy and hysterectomy and cancer incidence in the cancer prevention study-II nutrition cohort. Obstet Gynecol 123:1247–1255
Jain A, Polotsky AJ, Rochester D et al (2007) Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J Clin Endocrinol Metab 92:2468–2473
Rochester D, Jain A, Polotsky AJ et al (2009) Partial recovery of luteal function after bariatric surgery in obese women. Fertil Steril 92:1410–1415
Briskin C (2013) Progesterone signaling in breast cancer: a neglected hormone coming into the limelight. Nat Rev Cancer 13:385–396
Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA 288:321–333
Beral V, Reeves G, Bull D et al (2011) Breast cancer risk in relation to the interval between menopause and starting hormone therapy. J Natl Cancer Inst 103:296–305
Topal NB, Ayhan S, Topal U et al (2006) Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins. J Obstet Gynecol Res 32:305–308
Reeves GK, Pirie K, Beral V et al (2007) Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. BMJ. doi:10.1136/bmj.39367.495995.AE
Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579–591
Acknowledgments
We are grateful for support from the Royal Marsden/Institute of Cancer Research, National Institute for Health Research Biomedical Research Centre.
Conflict of interest
The authors declare that they have no conflict of interest
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dowsett, M., Folkerd, E. Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis. Breast Cancer Res Treat 149, 1–4 (2015). https://doi.org/10.1007/s10549-014-3211-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-014-3211-4